Immunogenicity after second and third mRNA-1273 vaccination doses in patients receiving chemotherapy, immunotherapy, or both for solid tumours

Sjoukje F Oosting; Astrid A M van der Veldt; Rudolf S N Fehrmann; Corine H GeurtsvanKessel; Rob S van Binnendijk; Anne-Marie C Dingemans; Egbert F Smit; T Jeroen N Hiltermann; Gerco den Hartog; Mathilda Jalving; Tatjana T Westphal; Arkajyoti Bhattacharya; Faye de Wilt; Annemarie Boerma; Lisanne van Zijl; Guus F Rimmelzwaan; Pia Kvistborg; Cecile A C M van Els; Nynke Y Rots; Debbie van Baarle; John B A G Haanen; Elisabeth G E de Vries

doi:10.1016/S1470-2045(22)00203-0

Immunogenicity after second and third mRNA-1273 vaccination doses in patients receiving chemotherapy, immunotherapy, or both for solid tumours

Lancet Oncol. 2022 Jul;23(7):833-835. doi: 10.1016/S1470-2045(22)00203-0. Epub 2022 Apr 25.

Authors

Sjoukje F Oosting¹, Astrid A M van der Veldt², Rudolf S N Fehrmann¹, Corine H GeurtsvanKessel³, Rob S van Binnendijk⁴, Anne-Marie C Dingemans⁵, Egbert F Smit⁶, T Jeroen N Hiltermann⁷, Gerco den Hartog⁴, Mathilda Jalving¹, Tatjana T Westphal⁸, Arkajyoti Bhattacharya¹, Faye de Wilt³, Annemarie Boerma⁹, Lisanne van Zijl¹⁰, Guus F Rimmelzwaan¹¹, Pia Kvistborg¹², Cecile A C M van Els¹³, Nynke Y Rots⁴, Debbie van Baarle⁹, John B A G Haanen¹⁰, Elisabeth G E de Vries¹

Affiliations

¹ Department of Medical Oncology, University Medical Centre Groningen, University of Groningen, Groningen, Netherlands.
² Department of Medical Oncology, Erasmus Medical Centre, 3015 GD Rotterdam, Netherlands; Department of Radiology and Nuclear Medicine, Erasmus Medical Centre, 3015 GD Rotterdam, Netherlands. Electronic address: [email protected].
³ Department of Viroscience, Erasmus Medical Centre, 3015 GD Rotterdam, Netherlands.
⁴ Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, Netherlands.
⁵ Department of Respiratory Medicine, Erasmus Medical Centre, 3015 GD Rotterdam, Netherlands.
⁶ Department of Thoracic Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands.
⁷ Department of Pulmonary Diseases, University Medical Centre Groningen, University of Groningen, Groningen, Netherlands.
⁸ Netherlands Comprehensive Cancer Organization, Utrecht, Netherlands.
⁹ Department of Medical Microbiology and Infection Prevention, University Medical Centre Groningen, University of Groningen, Groningen, Netherlands.
¹⁰ Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands.
¹¹ Research Centre for Emerging Infections and Zoonoses, University of Veterinary Medicine Hannover, Hannover, Germany.
¹² Department of Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, Netherlands.
¹³ Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, Netherlands; Department of Biomolecular Health Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, Netherlands.

No abstract available

MeSH terms

2019-nCoV Vaccine mRNA-1273*
Antibodies, Viral
Humans
Immunologic Factors / therapeutic use
Immunotherapy
Neoplasms* / drug therapy
Neoplasms* / genetics
Vaccination

Substances

Antibodies, Viral
Immunologic Factors
2019-nCoV Vaccine mRNA-1273